JP2005519849A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519849A5
JP2005519849A5 JP2003504964A JP2003504964A JP2005519849A5 JP 2005519849 A5 JP2005519849 A5 JP 2005519849A5 JP 2003504964 A JP2003504964 A JP 2003504964A JP 2003504964 A JP2003504964 A JP 2003504964A JP 2005519849 A5 JP2005519849 A5 JP 2005519849A5
Authority
JP
Japan
Prior art keywords
imidazo
amine
naphthyridin
methylpropyl
irm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003504964A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519849A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/018944 external-priority patent/WO2002102377A1/en
Publication of JP2005519849A publication Critical patent/JP2005519849A/ja
Publication of JP2005519849A5 publication Critical patent/JP2005519849A5/ja
Pending legal-status Critical Current

Links

JP2003504964A 2001-06-15 2002-06-14 歯周病の治療用免疫応答調節剤 Pending JP2005519849A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29876801P 2001-06-15 2001-06-15
PCT/US2002/018944 WO2002102377A1 (en) 2001-06-15 2002-06-14 Immune response modifiers for the treatment of periodontal disease

Publications (2)

Publication Number Publication Date
JP2005519849A JP2005519849A (ja) 2005-07-07
JP2005519849A5 true JP2005519849A5 (enExample) 2005-12-22

Family

ID=23151928

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003504964A Pending JP2005519849A (ja) 2001-06-15 2002-06-14 歯周病の治療用免疫応答調節剤

Country Status (5)

Country Link
EP (1) EP1401437A1 (enExample)
JP (1) JP2005519849A (enExample)
CN (1) CN1523987A (enExample)
CA (1) CA2449754A1 (enExample)
WO (1) WO2002102377A1 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741908A (en) 1996-06-21 1998-04-21 Minnesota Mining And Manufacturing Company Process for reparing imidazoquinolinamines
UA67760C2 (uk) 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6541485B1 (en) 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6573273B1 (en) 1999-06-10 2003-06-03 3M Innovative Properties Company Urea substituted imidazoquinolines
US6916925B1 (en) 1999-11-05 2005-07-12 3M Innovative Properties Co. Dye labeled imidazoquinoline compounds
US6545017B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Urea substituted imidazopyridines
UA74852C2 (en) 2000-12-08 2006-02-15 3M Innovative Properties Co Urea-substituted imidazoquinoline ethers
US6525064B1 (en) 2000-12-08 2003-02-25 3M Innovative Properties Company Sulfonamido substituted imidazopyridines
US6664265B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Amido ether substituted imidazoquinolines
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6545016B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Amide substituted imidazopyridines
US6677348B2 (en) 2000-12-08 2004-01-13 3M Innovative Properties Company Aryl ether substituted imidazoquinolines
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6660735B2 (en) 2000-12-08 2003-12-09 3M Innovative Properties Company Urea substituted imidazoquinoline ethers
CA2467828C (en) 2001-11-29 2011-10-04 3M Innovative Properties Company Pharmaceutical formulations comprising an immune response modifier
WO2004080430A2 (en) 2003-03-13 2004-09-23 3M Innovative Properties Company Methods of improving skin quality
CA2365732A1 (en) 2001-12-20 2003-06-20 Ibm Canada Limited-Ibm Canada Limitee Testing measurements
US6677349B1 (en) 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
PT1478327E (pt) 2002-02-22 2015-08-04 Meda Ab Método de redução e tratamento de imunossupressão induzida por uvb
JP2005538057A (ja) 2002-06-07 2005-12-15 スリーエム イノベイティブ プロパティズ カンパニー エーテル置換イミダゾピリジン
US7427629B2 (en) 2002-08-15 2008-09-23 3M Innovative Properties Company Immunostimulatory compositions and methods of stimulating an immune response
JP2006503068A (ja) 2002-09-26 2006-01-26 スリーエム イノベイティブ プロパティズ カンパニー １ｈ−イミダゾダイマー
EP1590348A1 (en) 2002-12-20 2005-11-02 3M Innovative Properties Company Aryl / hetaryl substituted imidazoquinolines
EP2572714A1 (en) 2002-12-30 2013-03-27 3M Innovative Properties Company Immunostimulatory Combinations
WO2004071459A2 (en) 2003-02-13 2004-08-26 3M Innovative Properties Company Methods and compositions related to irm compounds and toll-like receptor 8
US7485432B2 (en) 2003-02-27 2009-02-03 3M Innovative Properties Company Selective modulation of TLR-mediated biological activity
EP1601365A4 (en) 2003-03-04 2009-11-11 3M Innovative Properties Co PROPHYLACTIC TREATMENT OF UV-INDUCED EPIDERMAL NEOPLASIA
AU2004220465A1 (en) 2003-03-13 2004-09-23 3M Innovative Properties Company Method of tattoo removal
US20040192585A1 (en) 2003-03-25 2004-09-30 3M Innovative Properties Company Treatment for basal cell carcinoma
AU2004244962A1 (en) 2003-04-10 2004-12-16 3M Innovative Properties Company Delivery of immune response modifier compounds using metal-containing particulate support materials
US7176214B2 (en) 2003-05-21 2007-02-13 Bristol-Myers Squibb Company Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
JP2007503268A (ja) 2003-08-25 2007-02-22 スリーエム イノベイティブ プロパティズ カンパニー 免疫応答修飾化合物の送達
NZ545412A (en) 2003-08-27 2008-12-24 Coley Pharm Group Inc Aryloxy and arylalkyleneoxy substituted imidazoquinolines
WO2005020995A1 (en) * 2003-09-02 2005-03-10 3M Innovative Properties Company Methods related to the treatment of mucosal associated conditions
EP1673087B1 (en) 2003-10-03 2015-05-13 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
AU2004293078B2 (en) 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
JP2007513165A (ja) * 2003-12-02 2007-05-24 スリーエム イノベイティブ プロパティズ カンパニー Ｉｒｍ化合物を含む併用薬および治療方法
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
US20100160368A1 (en) 2008-08-18 2010-06-24 Gregory Jefferson J Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
EP2378876B1 (en) 2008-12-19 2018-11-14 Medicis Pharmaceutical Corporation Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis
MX336923B (es) 2009-07-13 2016-02-05 Medicis Pharmaceutical Corp Formulaciones de imiquimod de concentracion de dosificacion inferior y regimenes de dosificacion cortos para tratar verrugas genitales y perianales.
US20130023736A1 (en) 2011-07-21 2013-01-24 Stanley Dale Harpstead Systems for drug delivery and monitoring
JPWO2019216438A1 (ja) * 2018-05-11 2021-05-20 株式会社ジーンテクノサイエンス 間葉系細胞の培養上清を含む歯周病治療剤
CN114616234B (zh) * 2019-02-07 2024-04-12 康威(广州)生物科技有限公司 磷咪唑并喹啉胺衍生物、及其药物组合物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
US6541485B1 (en) * 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
JP2004504389A (ja) * 2000-07-13 2004-02-12 アルテオン　インコーポレーテッド シアノメチル置換化チアゾリウム及びイミダゾリウム、並びにタンパク質老化と関連する疾患の治療

Similar Documents

Publication Publication Date Title
US6825350B2 (en) Sulfonamide and sulfamide substituted imidazoquinolines and methods for the treatment of periodontal disease using these and other immune response modifiers
UA93496C2 (uk) Стерильний склад модифікатора імунної відповіді та способи одержання зазначеного складу
EP1509521B8 (en) 1h-imidazo[4,5-c]quinoline derivatives for the treatment of protein kinase dependent diseases
MA30967B1 (fr) Sels et formes cristallines de 2-methyl-2-methyl-2-[4-(3-methyl-2-oxo-8-quinolein-3-yl-2,3-dihydro-imidazo[4,5-c]quinolein-1-yl) - phenyl]-propionitrile.
IL171726A (en) Quinoline history, use of them @ for the manufacture @ drug @ for relief @ or @ treatment of a clinical condition in which there is an indication of selective pde4 inhibitor, their preparation and pharmaceutical compositions containing them
CA2449754A1 (en) Immune response modifiers for the treatment of periodontal disease
AU2003293460A1 (en) Novel application of biosensors for diagnosis and treatment of disease
JP2005528253A5 (enExample)
TN2011000626A1 (en) 1h-imidazo[4,5-c]quinolinone derivatives
IL166489A (en) Oral dosage form in single-dose administration containing at least two layers for the administration and use of flipridone
EP1578385A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF INFLAMMATORY ENDURANCE DISEASES
EP1539251A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND THERAPY OF MEDICAL DISEASES WITH ANGIOGENESIS
JP2008533148A5 (enExample)
HUP0201664A2 (en) Urea substituted imidazoquinolines
HUP0000450A2 (hu) 7-(2-Oxa-5,8-diazabiciklo[4.3.0]non-8-il)-kinolon-karbonsav és -naftiridon-karbonsav-származékok alkalmazása Helicobacter pylori fertőzések, és az ezzel kapcsolatos gyomor-bél megbetegedések gyógyítására szolgáló gyógyszerkészítmények előállítására
JP2005508338A5 (enExample)
JP2004517824A5 (enExample)
EP1393734A4 (en) DRUG AGAINST DARMER DISEASES
CN1784212A (zh) 口腔护理方法和产品
HUP0500028A2 (hu) Triaza-spiro[5.5]undekán-azármazék citokróm P450 izozim 3A4 inhibitorral és/vagy P-glikoprotein inhibitorral való kombinációját tartalmazó gyógyszer
JP2005524666A5 (enExample)
EP2275110A3 (en) Cladribine regimen for treating Multiple Sclerosis
JP2005179268A (ja) 口腔用組成物
JP2004502653A5 (enExample)
Qi et al. Comparison of curative effect between different retrograde filling materials in young permanent molar root canal therapy